Reduced-dose Versus Conventional-dose Intensity-modulated Radiation Therapy for Locally Advanced Nasopharyngeal Carcinoma With Remission After Induction Chemotherapy and Immunotherapy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ming-Yuan Chen, MD,PhD
Sun Yat-sen University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cancer Center of Guangzhou Medical University
Guangzhou, Guangdong, China
Recruiting - Sun Yat-Sen University Cancer Center
Guangzhou, Guangdong, China
Recruiting - the Fifth Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China
Recruiting - the Second Affiliated Hospital of Sun Yat-Sen University (sysu)
Guangzhou, Guangdong, China
Recruiting - Cancer Hospital of Shantou University Medical College
Shantou, Guangdong, China
Recruiting - Zhongshan City People'S Hospital
Zhongshan, Guangdong, China
Recruiting - the People'S Hospital of Guangxi Zhuang Autonomous Region
Nanning, Guangxi, China
Recruiting - Wuzhou Red Cross Hospital
Wuzhou, Guangxi, China
Recruiting - Tongji Hospital Affiliated To Tongji Medical College of Huazhong University of Science and Technology
Wuhan, Hubei, China
Recruiting - Central South University Cancer Hospital
Changsha, Hunan, China
Recruiting - Xiangya Hospital of Central South University
Changsha, Hunan, China
Recruiting - the Fifth Affiliated Hospital of Sun Yat-Sen University
Guangdong, Zhuhai, China
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 18 Nov 2025
- Primary completion
- 30 Jun 2030
- Completion
- 30 Jun 2032
- Last update posted
- 9 Jan 2026
- Registered enrollment
- 456
- Registry id
- NCT07328841
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.